Barbara Ann Karmanos Cancer Institute

Clinical research site in Lansing, Michigan

Part of Barbara Ann Karmanos Cancer Institute

As of July 2026, 1 paid clinical trial is recruiting at Barbara Ann Karmanos Cancer Institute in Lansing, Michigan. Active studies at this site focus on Metastatic Castration-resistant Prostate Cancer alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Barbara Ann Karmanos Cancer Institute (1)

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

34 locations incl. Goodyear

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT07213674·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

More research sites in Lansing

University of Michigan Health - Sparrow Lansing (67 trials)
Karmanos Cancer Institute at McLaren Greater Lansing (20 trials)
Sparrow Clinical Research Institute (6 trials)
Alkermes Investigational Site (4 trials)
Clinical Trial Site (2 trials)
June DO, PC (2 trials)
Michigan State University (2 trials)
Sparrow Cancer Center (2 trials)
Sparrow Hospital (2 trials)
Advanced Rheumatology PC | Lansing, MI (1 trial)

Explore more

Paid clinical trials in Lansing, MI · Michigan clinical trials